(Q42815166)

English

Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic γδ T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitro

scientific article published on 5 November 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

7 November 2017

Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic γδ T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitro (English)

1 reference

Europe PubMed Central

7 November 2017

0 references

corrigendum / erratum

Erratum: Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic γδ T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitro

1 reference

10.1038/LEU.2011.102

12 July 2019

http://api.crossref.org/works?select=update-to&filter=doi:10.1038/LEU.2011.102

14

1 reference

Europe PubMed Central

7 November 2017

author name string

J Iqbal

1

1 reference

Europe PubMed Central

7 November 2017

D D Weisenburger

2

1 reference

Europe PubMed Central

7 November 2017

A Chowdhury

3

1 reference

Europe PubMed Central

7 November 2017

M Y Tsai

4

1 reference

Europe PubMed Central

7 November 2017

G Srivastava

5

1 reference

Europe PubMed Central

7 November 2017

T C Greiner

6

1 reference

Europe PubMed Central

7 November 2017

C Kucuk

7

1 reference

Europe PubMed Central

7 November 2017

K Deffenbacher

8

1 reference

Europe PubMed Central

7 November 2017

J Vose

9

1 reference

Europe PubMed Central

7 November 2017

L Smith

10

1 reference

Europe PubMed Central

7 November 2017

W Y Au

11

1 reference

Europe PubMed Central

7 November 2017

S Nakamura

12

1 reference

Europe PubMed Central

7 November 2017

M Seto

13

1 reference

Europe PubMed Central

7 November 2017

F Berger

15

1 reference

Europe PubMed Central

7 November 2017

F Loong

16

1 reference

Europe PubMed Central

7 November 2017

Y-H Ko

17

1 reference

Europe PubMed Central

7 November 2017

I Sng

18

1 reference

Europe PubMed Central

7 November 2017

X Liu

19

1 reference

Europe PubMed Central

7 November 2017

T P Loughran

20

1 reference

Europe PubMed Central

7 November 2017

J Armitage

21

1 reference

Europe PubMed Central

7 November 2017

W C Chan

22

1 reference

Europe PubMed Central

7 November 2017

International Peripheral T-cell Lymphoma Project

23

1 reference

Europe PubMed Central

7 November 2017

publication date

5 November 2010

1 reference

Europe PubMed Central

7 November 2017

1 reference

Europe PubMed Central

7 November 2017

25

1 reference

Europe PubMed Central

7 November 2017

348-358

1 reference

Europe PubMed Central

7 November 2017

2

1 reference

Europe PubMed Central

7 November 2017

describes a project that uses

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

0 references

https://scigraph.springernature.com/pub.10.1038/leu.2010.255

0 references

Leukemia and lymphoma of natural killer lineage cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.255

21 January 2018

International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.255

21 January 2018

Large granular lymphocyte leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.255

21 January 2018

Clinical differences between nasal and extranasal natural killer/T-cell lymphoma: a study of 136 cases from the International Peripheral T-Cell Lymphoma Project

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.255

21 January 2018

Nasal T/natural killer (NK)-cell lymphomas are derived from Epstein-Barr virus-infected cytotoxic lymphocytes of both NK- and T-cell lineage

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.255

21 January 2018

WHO-EORTC classification for cutaneous lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.255

21 January 2018

Expression of interleukin-9 in nasal natural killer/T-cell lymphoma cell lines and patients

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.255

21 January 2018

Reduction of hematopoietic cell-specific tyrosine phosphatase SHP-1 gene expression in natural killer cell lymphoma and various types of lymphomas/leukemias : combination analysis with cDNA expression array and tissue microarray

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.255

21 January 2018

Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.255

21 January 2018

Gene expression profiling of peripheral T-cell lymphoma including gammadelta T-cell lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.255

21 January 2018

Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.255

21 January 2018

Characterization of novel natural killer (NK)-cell and gammadelta T-cell lines established from primary lesions of nasal T/NK-cell lymphomas associated with the Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.255

21 January 2018

Genome wide transcriptional analysis of resting and IL2 activated human natural killer cells: gene expression signatures indicative of novel molecular signaling pathways

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.255

21 January 2018

A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.255

21 January 2018

Significance analysis of microarrays applied to the ionizing radiation response

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.255

21 January 2018

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.255

21 January 2018

Investigating the relationship between the cell cycle and apoptosis using flow cytometry

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.255

21 January 2018

Preferential expansion of Vgamma9-JgammaP/Vdelta2-Jdelta3 gammadelta T cells in nasal T-cell lymphoma and chronic active Epstein-Barr virus infection

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.255

21 January 2018

Helios, a T cell-restricted Ikaros family member that quantitatively associates with Ikaros at centromeric heterochromatin

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.255

21 January 2018

Cloning and characterization of human Lnk, an adaptor protein with pleckstrin homology and Src homology 2 domains that can inhibit T cell activation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.255

21 January 2018

Aberrant expression of the tyrosine kinase receptor EphA4 and the transcription factor twist in Sézary syndrome identified by gene expression analysis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.255

21 January 2018

Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.255

21 January 2018

Aurora-A kinase regulates telomerase activity through c-Myc in human ovarian and breast epithelial cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.255

21 January 2018

Aurora kinase A is a target of Wnt/beta-catenin involved in multiple myeloma disease progression

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.255

21 January 2018

Aurora-A abrogation of p53 DNA binding and transactivation activity by phosphorylation of serine 215.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.255

21 January 2018

Transcriptional regulation of serine/threonine kinase-15 (STK15) expression by hypoxia and HIF-1.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.255

21 January 2018

Monomorphic agranular natural killer cell lymphoma/leukemia with no Epstein-Barr virus association

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.255

21 January 2018

A novel natural killer cell line (KHYG-1) from a patient with aggressive natural killer cell leukemia carrying a p53 point mutation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.255

21 January 2018

A new human natural killer leukemia cell line, IMC-1. A complex chromosomal rearrangement defined by spectral karyotyping: functional and cytogenetic characterization

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.255

21 January 2018

Common cytological and cytogenetic features of Epstein-Barr virus (EBV)-positive natural killer (NK) cells and cell lines derived from patients with nasal T/NK-cell lymphomas, chronic active EBV infection and hydroa vacciniforme-like eruptions

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.255

21 January 2018

Gammadelta T cells: functional plasticity and heterogeneity

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.255

21 January 2018

Hepatosplenic and subcutaneous panniculitis-like gamma/delta T cell lymphomas are derived from different Vdelta subsets of gamma/delta T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.255

21 January 2018

Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.255

21 January 2018

Structure of the p53 binding domain of HAUSP/USP7 bound to Epstein-Barr nuclear antigen 1 implications for EBV-mediated immortalization

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.255

21 January 2018

Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.255

21 January 2018

Structural basis of Aurora-A activation by TPX2 at the mitotic spindle

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.255

21 January 2018

Human TPX2 is required for targeting Aurora-A kinase to the spindle

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.255

21 January 2018

The case for Survivin as mitotic regulator

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.255

21 January 2018

Radiotherapy as primary treatment for stage IE and IIE nasal natural killer/T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.255

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification of a T cell lymphoma category derived from intestinal-mucosa-associated T cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.255

7 January 2021

based on heuristic

inferred from DOI database lookup

Subcutaneous panniculitic T-cell lymphoma is a tumor of cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.255

7 January 2021

based on heuristic

inferred from DOI database lookup

A major fraction of human intraepithelial lymphocytes simultaneously expresses the γ/δ T cell receptor, the CD8 accessory molecule and preferentially uses the Vδ1 gene segment

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.255

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatosplenic T-cell lymphoma: an unusual case of a gamma delta T-cell lymphoma with a blast-like terminal transformation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.255

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytotoxic protein expression in natural killer cell lymphomas and in alpha beta and gamma delta peripheral T-cell lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.255

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/LEU.2010.255

1 reference

Europe PubMed Central

7 November 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

7 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42815166&oldid=1971039263"